Recent Trials

Colombia

Alecardio
Spire I & II

Alecardio

Effect Of Aleglitazar On Cardiovascular Outcomes After Acute Coronary Syndrome With Type 2 Diabetes Mellitus.

Study Metrics

Sites Initiated

32

Sites Randomized

29

Patients Screened

668

Patients Randomized

612

Trials in Other Countries

Argentina - Brazil - Mexico

Mexico

Trials

Argentina

Trials

Brazil

Trials

Interested in Latin America?

Request a free consultation with our regional experts